HBF AND A1M AS EARLY STAGE MARKERS FOR PREECLAMPSIA
摘要
<p>A method for diagnosing or predicting the risk of developing preeclampsia by measuring the level of A1 M and one or more of the compounds HbA, HbF in a sample and comparing the obtained values with reference values. By using a combination of information relating to A1 M and HbF improved diagnose or prediction is observed.</p>
申请公布号
WO2011116958(A1)
申请公布日期
2011.09.29
申请号
WO2011EP01458
申请日期
2011.03.24
申请人
PREELUMINA DIAGNOSTICS AB;AKERSTROEM, BO;OLSSON, MAGNUS;HANSSON, STEFAN
